Atika Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-59,100
| Closed | -$10.1M | – | 111 |
|
|
2020
Q4 | $10.1M | Buy |
59,100
+5,100
| +9% | +$870K | 0.79% | 53 |
|
|
2020
Q3 | $7.58M | Sell |
54,000
-6,000
| -10% | -$843K | 0.62% | 48 |
|
|
2020
Q2 | $9.62M | Buy |
60,000
+8,600
| +17% | +$1.38M | 1.24% | 27 |
|
|
2020
Q1 | $5.03M | Sell |
51,400
-20,600
| -29% | -$2.02M | 0.96% | 31 |
|
|
2019
Q4 | $9.29M | Buy |
+72,000
| New | +$9.29M | 1.79% | 16 |
|
|
2019
Q3 | – | Sell |
-92,000
| Closed | -$14M | – | 79 |
|
|
2019
Q2 | $14M | Buy |
92,000
+2,000
| +2% | +$304K | 2.75% | 3 |
|
|
2019
Q1 | $10.7M | Buy |
90,000
+11,900
| +15% | +$1.42M | 2.18% | 5 |
|
|
2018
Q4 | $8.52M | Sell |
78,100
-900
| -1% | -$98.2K | 2.51% | 8 |
|
|
2018
Q3 | $12.8M | Buy |
79,000
+7,000
| +10% | +$1.13M | 2.29% | 2 |
|
|
2018
Q2 | $9.52M | Sell |
72,000
-25,000
| -26% | -$3.3M | 1.83% | 5 |
|
|
2018
Q1 | $7.19M | Buy |
97,000
+5,000
| +5% | +$370K | 2.46% | 9 |
|
|
2017
Q4 | $5.12M | Sell |
92,000
-8,000
| -8% | -$445K | 1.98% | 16 |
|
|
2017
Q3 | $4.54M | Buy |
+100,000
| New | +$4.54M | 1.3% | 14 |
|